INFLUENCE OF DOSAGE FORM ON PAPAVERINE BIOAVAILABILITY

被引：8

作者：

MEYER, MC ^{[1
]}

GOLLAMUDI, R ^{[1
]}

STRAUGHN, AB ^{[1
]}

机构：

[1] UNIV TENNESSEE,CTR HLTH SCI,COLL PHARM,DEPT MED CHEM,MEMPHIS,TN 38163

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 1979年 / 19卷 / 8-9期

关键词：

D O I：

10.1002/j.1552-4604.1979.tb02505.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：435 / 444

页数：10

共 20 条

[11] GLC DETERMINATION OF PAPAVERINE IN BIOLOGICAL-FLUIDS [J].

GUTTMAN, DE ;

KOSTENBAUDER, HB ;

WILKINSON, GR ;

DUBE, PH .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (10) :1625-1626

[12]

JUHRAN W, 1975, ARZNEIMITTEL-FORSCH, V25, P771

[13]

LEE BY, 1978, INT J CLIN PHARM BI, V16, P32

[14]

NICKERSON M, 1975, PHARMACOL BASIS, P735

[15]

RITSCHEL WA, 1977, INT J CLIN PHARM BI, V15, P227

[16] INVITRO EVALUATION OF 3 COMMERCIAL SUSTAINED-RELEASE PAPAVERINE HYDROCHLORIDE PRODUCTS [J].

TIMKO, RJ ;

LORDI, NG .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (04) :496-500

[17]

WANG HS, 1976, BIOL PSYCHIAT, V11, P217

[18] EXPERIMENTAL DESIGNS BALANCED FOR THE ESTIMATION OF RESIDUAL EFFECTS OF TREATMENTS [J].

WILLIAMS, EJ .

AUSTRALIAN JOURNAL OF SCIENTIFIC RESEARCH SERIES A-PHYSICAL SCIENCES, 1949, 2 (02) :149-168

[19]

1976, FED REG 14405 0405, V41

[20]

1973, AMA DRUG EVALUATIONS, P30

← 1 2 →